Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | SI | P14410 | 1/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.42 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.42 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28901707 | 0.97 | ALDH1A1 (0.43) | ALDH1A1LMNAHSD17B10HPGDALOX15 | |
| SCHEMBL10805459 | 0.97 | ALDH1A1 (0.43) | ALDH1A1LMNAHSD17B10HPGDALOX15 | |
| SCHEMBL11419221 | 0.93 | ALDH1A1 (0.40) | ALDH1A1LMNAHSD17B10HPGDALOX15 | |
| SCHEMBL141446 | 0.86 | ALDH1A1 (0.53) | ALDH1A1LMNAHSD17B10HPGDALOX15 | |
| Ethane SCHEMBL9181718 | 0.83 | ALDH1A1 (0.50) | ALDH1A1LMNAHSD17B10HPGDALOX15 | |
| SCHEMBL28186389 | 0.83 | ALDH1A1 (0.50) | ALDH1A1LMNAHSD17B10HPGDALOX15 | |
| Ammonia Solution, Strong SCHEMBL28791130 | 0.83 | ALDH1A1 (0.50) | ALDH1A1LMNAHSD17B10HPGDALOX15 | |
| SCHEMBL8800602 | 0.83 | ALDH1A1 (0.50) | ALDH1A1LMNAHSD17B10HPGDALOX15 | |
| SCHEMBL5143571 | 0.81 | ALDH1A1 (0.48) | ALDH1A1LMNAHSD17B10HPGDALOX15 | |
| SCHEMBL27541468 | 0.81 | MAPT (0.46) | ALDH1A1LMNAHSD17B10HPGDALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110511793-A | A kind of compound special oil of super kitchen and preparation method thereof | ZHANG YING | 2019-11-29 | — | — | CN | claimed |
| CN-108383998-B | A kind of high intensity humidity response polyhydroxyamide and preparation method thereof | 安徽农业大学 | 2019-10-08 | — | — | CN | claimed |
| CN-106543314-B | The application of catalyst containing ether ester and the catalyst and ether ester in olefin polymerization | 中国石油化工股份有限公司 | 2019-02-19 | — | — | CN | claimed |
| CN-106966926-B | A kind of preparation method of LCZ696 intermediates | 沧州那瑞化学科技有限公司 | 2018-10-19 | — | — | CN | claimed |
| CN-108383998-A | A kind of high intensity humidity response polyhydroxyamide and preparation method thereof | 安徽农业大学 | 2018-08-10 | — | — | CN | claimed |
| CN-107099358-A | Alcohol-based fuel preservative | 马健 | 2017-08-29 | — | — | CN | claimed |
| CN-106966926-A | A kind of preparation method of LCZ696 intermediates | 沧州那瑞化学科技有限公司 | 2017-07-21 | — | — | CN | claimed |
| CN-106543310-A | A kind of olefin polymerization catalyst system and its application | 中国石油化工股份有限公司 | 2017-03-29 | — | — | CN | claimed |
| EP-1907503-A1 | CORROSION INHIBITOR OR INTENSIFIER FOR USE IN ACIDIZING TREATMENT FLUIDS | Halliburton Energy Services, Inc. (US) | 2008-04-09 | — | — | EP | claimed |
| WO-2007007025-A1 | CORROSION INHIBITOR OR INTENSIFIER FOR USE IN ACIDIZING TREATMENT FLUIDS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2007-01-18 | — | — | WO | claimed |
| US-20070010404-A1 | Corrosion inhibitor or intensifier for use in acidizing treatment fluids | HALLIBURTON ENERGY SERVICES, INC. | 2007-01-11 | — | — | US | claimed |
| US-6415614-B1 | CONTROLLING VAPOR PRESSURE OF MIXTURE | VISTEON GLOBAL TECHNOLOGIES, INC. | 2002-07-09 | — | — | US | claimed |
| EP-0037973-B1 | PROCESS FOR THE SYNTHESIS OF ESTRONE OR ESTRONE DERIVATIVES | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-05-30 | — | — | EP | claimed |
| US-4357278-A | Process for synthesizing estrone or estrone derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-11-02 | — | — | US | claimed |
| EP-4329735-B1 | KCNT1 INHIBITORS AND METHODS OF USE | PRAXIS PREC MEDICINES INC (US) | 2026-02-25 | — | — | EP | disclosed |
| US-20250346613-A1 | BORIC ACID PROTEASOME INHIBITOR AND USE THEREOF | ARTIVILA BIOPHARMA (CN) | 2025-11-13 | — | — | US | disclosed |
| US-12389910-B2 | Beta-lactams and their use as herbicides | BASF SE (DE) | 2025-08-19 | — | — | US | disclosed |
| US-4086338-A | HYPOTENSIVE AGENTS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS | E. R. SQUIBB & SONS, INC. (US) | 1978-04-25 | — | — | US | disclosed |
| US-4052511-A | ANGIOTENSIN CONVERTING ENZYME INHIBITORS | E. R. SQUIBB & SONS, INC. (US) | 1977-10-04 | — | — | US | disclosed |
| US-4036629-A | PLANT GROWTH REGULATORS, FUNGICIDES, HERBICIDES | MOBIL OIL CORPORATION (US) | 1977-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346613-A1 | BORIC ACID PROTEASOME INHIBITOR AND USE THEREOF | PSMA1, PSMB11, PSMB1 | ALDH1A1 2948/4885LMNA 2565/4885HSD17B10 2975/4885 |
| US-12389910-B2 | Beta-lactams and their use as herbicides | POLL, HDHD5, GLRB | ALDH1A1 753/4885LMNA 1993/4885HSD17B10 220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.